JPM2026

News

Illumina says its new Billion Cell Atlas can be used to identify and validate drug targets and train AI models used in drug discovery.

R&D

Radiotherapeutics have tremendous potential, but only a few therapies in market. But the technology is getting closer to its breakthrough moment.

R&D

At the Sachs Neuroscience Forum just before the start of JPM 2026 in San Francisco, pharmaphorum spoke with Amit Etkin, CEO of Alto Neuroscience.

News

Anthropic has launched Claude for Healthcare, a suite of AI tools designed for health systems, payers, and patients.

News

New data from the UK medicines regulator has shown an increase in clinical trial activity in the country, after years of decline.

News

Global chipmaker giant NVIDIA kicked off JPM Week with several partnership announcements, including a billion dollar partnership with Eli Lilly.